AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 199 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $548,179 | -8.9% | 23,865 | +11.4% | 0.03% | -17.5% |
| Q4 2022 | $601,754 | -0.7% | 21,430 | +0.1% | 0.04% | 0.0% |
| Q3 2022 | $606,000 | +1.5% | 21,411 | -20.5% | 0.04% | +25.0% |
| Q2 2022 | $597,000 | -7.3% | 26,940 | +21.7% | 0.03% | -5.9% |
| Q1 2022 | $644,000 | +4.4% | 22,138 | +18.0% | 0.03% | -8.1% |
| Q4 2021 | $617,000 | -56.2% | 18,756 | -38.5% | 0.04% | -53.2% |
| Q3 2021 | $1,408,000 | +30.6% | 30,512 | +56.0% | 0.08% | +36.2% |
| Q2 2021 | $1,078,000 | +41.1% | 19,565 | +32.2% | 0.06% | +31.8% |
| Q1 2021 | $764,000 | +4.2% | 14,800 | -12.5% | 0.04% | -17.0% |
| Q4 2020 | $733,000 | -60.7% | 16,908 | -68.3% | 0.05% | -13.1% |
| Q3 2020 | $1,867,000 | +13.4% | 53,349 | +73.2% | 0.06% | +45.2% |
| Q2 2020 | $1,647,000 | +688.0% | 30,801 | +424.0% | 0.04% | +600.0% |
| Q1 2020 | $209,000 | -40.3% | 5,878 | -45.5% | 0.01% | +50.0% |
| Q3 2019 | $350,000 | – | 10,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 965,369 | $56,378,000 | 14.98% |
| Casdin Capital, LLC | 237,500 | $13,870,000 | 8.18% |
| BB BIOTECH AG | 2,839,528 | $165,828,000 | 5.42% |
| Opaleye Management Inc. | 130,000 | $7,592,000 | 3.78% |
| Redmile Group, LLC | 902,578 | $52,711,000 | 3.42% |
| Clarius Group, LLC | 109,230 | $6,379,000 | 2.63% |
| Opus Point Partners Management, LLC | 57,410 | $3,353,000 | 2.49% |
| Ghost Tree Capital, LLC | 125,000 | $7,300,000 | 1.36% |
| CAPITAL INTERNATIONAL LTD /CA/ | 346,937 | $20,261,000 | 1.32% |
| Eventide Asset Management | 300,800 | $17,567,000 | 1.16% |